Who is sponsoring NCT05521594?

NCT05521594 is sponsored by Qena Oncology Center.

What drugs are being tested in NCT05521594?

Interventions in NCT05521594: Fine Needle Aspiration Cytology.

What condition does NCT05521594 study?

NCT05521594 studies Fine Needle Aspiration Cytology, Thyroid Diseases.

Is NCT05521594 still recruiting?

NCT05521594 is currently completed. Last updated 26 September 2022.

Last reviewed 2022-09-26 · How we verify

NCT05521594: Thyroid FNAC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Accuracy of FNAC in Thyroid Nodules Compared to to Surgical Specimen : QOC Experience

Completed NA Last updated 26 September 2022

What this trial tests

NA trial testing Fine Needle Aspiration Cytology in Fine Needle Aspiration Cytology in 86 participants. Completed in 31 July 2022.

Timeline

1 January 2021

Primary endpoint
30 June 2022

31 July 2022

Quick facts

Lead sponsor	Qena Oncology Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	86
Start date	1 January 2021
Primary completion	30 June 2022
Estimated completion	31 July 2022
Sites	1 location across Egypt

Drugs / interventions tested

Fine Needle Aspiration Cytology

Conditions studied

Fine Needle Aspiration Cytology — all drugs for Fine Needle Aspiration Cytology →
Thyroid Diseases — all drugs for Thyroid Diseases →

Sponsor

Qena Oncology Center

Who can join

Adults 15 to 80, any sex, with Fine Needle Aspiration Cytology or Thyroid Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Thyroid gland diseases are the second most common endocrine disease following diabetes mellitus(1). Thyroid nodules are common disorders with a prevalence ranged from 4 to 7% in adult population, 5%-30% are malignant \[1\].Fine-needle aspiration cytology (FNAC) is an easy, cost-effective test for cancer diagnosis, and its use has markedly decreased the number of unnecessary thyroid surgeries(2).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Fine Needle Aspiration Cytology

Trials testing the same drug.

NCT03849482 — Multiparametric Magnetic Resonance Imaging Versus Fine Needle Aspiration Cytology for Parotid Gland Neoplasms · unknown

Other Qena Oncology Center trials

Trials by the same sponsor.

NCT05367869 — Impact of Intraoperative Spraying Methylene Blue In Thyroidectomy · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05521594 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Qena Oncology Center
Last refreshed: 26 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05521594.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing